Open access
Aug 2026
CLTR-03 IMPACT-MET: A PHASE I STUDY TO ASSESS SAFETY AND FEASIBILITY OF IL-8 RECEPTOR MODIFIED, PATIENT-DERIVED, ACTIVATED CD70 CAR T CELL THERAPY IN ADULTS WITH BRAIN METASTASES FROM PRIMARY CANCERS
This study will evaluate the safety and feasibility of 8R-70CAR T cells in BM patients and may inform on the future development of 8R-70CAR T cell therapy in this population.
Taryn King, A. Fares, P. Deleyrolle et al.
· Neuro-Oncology Advances · 1 citation